Tag: Covid

The purpose of this clinical trial is to test the safety and effectiveness of additional COVID-19 booster doses in people who have already received a primary COVID-19 vaccination series and booster dose. Participants will have completed a primary COVID-19 vaccination series (2 doses of Pfizer, 2 doses of Moderna, or 1 dose of Johnson & Johnson) and received a booster at least 16 weeks prior to joining the study.

This is a Phase 1/2 COVID-19 vaccine booster trial.  The purpose of this clinical trial is to test the safety and effectiveness of a booster dose of the Novavax sub-unit protein vaccine in people who have received an EUA vaccine series.

The purpose of this trial is to test investigational chimpanzee Adenovirus and self-amplifying mRNA prime-boost prophylactic vaccines against SARS-CoV-2 in healthy adults.

This is a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or CoVPN – and Novavax as the pharmaceutical partner.